NCEL
NewcelX Ltd.
NASDAQ · Healthcare · Biotechnology · CH
$3.35
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
2.0%
Return on equity
1.3%
Return on assets
-134.9%
Return on invested capital
0.00x
Asset turnover
-$6.3M
Cash from operations
$0.41
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025